AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 6,180.00
+120.00 (1.98%)
Aug 14, 2026, 3:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 173.62 billion as of August 14, 2026. Its market cap has decreased by -21.71% in one year.
Market Cap
173.62B
Enterprise Value
169.44B
Revenue
4.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,180.00
ChartMarket Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 173.62B, a decrease of -58.98%. That is a compound annual growth rate of -11.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 173.62B | -30.92% |
| Dec 30, 2025 | 251.34B | 46.78% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chong Kun Dang Holdings | 189.95B |
| Whan In Pharm | 187.98B |
| REYON Pharmaceutical | 184.88B |
| BNC KOREA | 183.98B |
| Hyundai Pharmaceutical | 179.63B |
| JW Lifescience | 177.14B |
| Daewon Pharmaceutical | 171.04B |
| Daihan Pharmaceutical | 158.47B |